These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19349124)

  • 1. Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis.
    Ji JD; Woo JH; Choi SJ; Lee YH; Song GG
    Med Hypotheses; 2009 Aug; 73(2):201-2. PubMed ID: 19349124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation endproducts in osteoporosis--is there a pathophysiologic importance?
    Hein GE
    Clin Chim Acta; 2006 Sep; 371(1-2):32-6. PubMed ID: 16777084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis in rheumatoid arthritis].
    Suzuki Y; Uehara R; Ide M; Ichikawa Y
    Nihon Rinsho; 1998 Jun; 56(6):1598-603. PubMed ID: 9648488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis. Fractures in patients with rheumatoid arthritis].
    Furuya T; Nanke Y; Kotake S
    Clin Calcium; 2007 Sep; 17(9):1429-34. PubMed ID: 17767035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A; Saito E; Wakabayashi T; Suzuki Y
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases.
    Soory M
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):13-25. PubMed ID: 12477294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoporosis associated with rheumatoid arthritis].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2003 Feb; 61(2):292-8. PubMed ID: 12638224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic intervention of rheumatoid arthritis bone loss].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2013 Sep; 23(9):1345-52. PubMed ID: 23999372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.
    Yamagishi S; Nakamura K; Matsui T; Ueda S; Noda Y; Imaizumi T
    Cardiovasc Ther; 2008; 26(1):50-8. PubMed ID: 18466420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy for osteoporosis associated with rheumatoid arthritis (vitamin D)].
    Tsurukami H; Nakamura T
    Clin Calcium; 2001 May; 11(5):623-7. PubMed ID: 15775565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology, diagnosis and treatment of osteoporosis].
    Tsurukami H
    Clin Calcium; 2003 Jun; 13(6):722-7. PubMed ID: 15775142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings.
    Hein G; Weiss C; Lehmann G; Niwa T; Stein G; Franke S
    Ann Rheum Dis; 2006 Jan; 65(1):101-4. PubMed ID: 16344492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
    Coulson KA; Reed G; Gilliam BE; Kremer JM; Pepmueller PH
    J Clin Rheumatol; 2009 Jun; 15(4):155-60. PubMed ID: 19363452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Dec; 71(6):876-8. PubMed ID: 18783891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O; Delle Sedie A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis in collagen diseases].
    Momohara S; Aritomi H
    Nihon Rinsho; 1994 Sep; 52(9):2420-5. PubMed ID: 7967091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease.
    Dalbeth N; Smith T; Gray S; Doyle A; Antill P; Lobo M; Robinson E; King A; Cornish J; Shalley G; Gao A; McQueen FM
    Ann Rheum Dis; 2009 Feb; 68(2):279-82. PubMed ID: 18765428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy for osteoporosis associated with reumatoid arthritis (bisphosphonates)].
    Hosoi T
    Clin Calcium; 2001 May; 11(5):619-22. PubMed ID: 15775564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.